| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 627745 | Null | 0.0119653763676522 | 0.25348088 |
| NSC 102225 | Null | 0.0133986477026051 | 0.23192197 |
| NSC 114340 | Ophiobolin A | 0.0133986477026051 | 0.023147556 |
| NSC 132277 | Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) | 0.0133986477026051 | 0.22836383 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0133986477026051 | 0.21957571 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0133986477026051 | 0.062560516 |
| NSC 168516 | Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | 0.0133986477026051 | 0.15002807 |
| NSC 261726 | ICN 4221 | 0.0133986477026051 | 0.23211765 |
| NSC 330507 | Tanespimycin | 0.0133986477026051 | -0.034202216 |
| NSC 375162 | Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide | 0.0133986477026051 | 0.14203998 |